Lazard acted as TPI’s financial advisor. Goodwin Procter LLP acted as TPI’s legal advisor and Sullivan & Cromwell LLP acted as Oaktree’s legal advisor. TPI Composites,...
TPI Composites, Inc.’s Refinancing Transaction with Oaktree
Subject Matter’s Acquisition of Kivvit
Goodwin Procter advised Subject Matter, and Seyfarth Shaw advised Kivvit. Subject Matter, a portfolio company of Coral Tree Partners, announced its acquisition of Kivvit to create...
Onex’s Investment in Unanet
Goodwin Procter advised Unanet and JMI Equity on the deal, while Latham & Watkins represented Onex. Unanet announced a new round of strategic financing from Onex Corporation...
FibroGen’s Royalty Monetization Financing with NovaQuest Capital Management
Goodwin Procter advised FibroGen, Inc. on the deal. FibroGen, Inc. announced its capped royalty monetization financing with NovaQuest Capital Management. The non-dilutive financing provides FibroGen with...
TA Associates’ Investment in Veracode
Goodwin Procter advised TA Associates on the deal. TA Associates announced its strategic growth investment in Veracode, taking a majority equity position in the business. Veracode is...
Dutchie’s $350 Million Series D Financing Round
Goodwin Procter advised Dutchie on the deal, while Paul, Weiss advised D1 Capital Partners. Dutchie announced its $350 million Series D financing round. Dutchie is now valued...
Amplitude’s Direct listing of Class A Common Stock
Goodwin advised Morgan Stanley on the deal, while Latham & Watkins represented Amplitude. Amplitude, Inc., a pioneer in digital optimization, announced that, as of September 22, 2021,...
Doximity’s $605.8 Million IPO
Goodwin Procter LLP advised Doximity on the deal. Doximity (NYSE: DOCS) announced its initial public offering of 23,300,000 shares of its Class A common stock at a...